Meningoencephalitis from Borrelia Miyamotoi in an Immunocompromised Patient
NEJM 368:240-245, Gugliotta, J.L.,et al, 2013
Long-Term Improvement of Musicians Dystonia after Stereotactic Ventro-Oral Thalamotomy
Ann Neurol 74:648-654,627, Horisawa, S.,et al, 2013
Continuous and Routine EEG in Intensive Care
Neurol 81:2002-2008, Ney, J.P.,et al, 2013
Encephalitis and GABAb Receptor Antibodies
Neurol 81:1500-1506, H�ftberger, R.,et al, 2013
Mystery Case: A Young Boy with Myoclonic Jerks
Neurol 81:e130-e134, Musleh, C.,et al, 2013
Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Ann Neurol 73:705-713, Khan, O.,et al, 2013
Target Sign on Enhanced MR Imaging in Toxoplasmosis
Conn Med 77:343-344, Finelli, P.F. & Al Zahmi, F., 2013
Overlooked non-motor Symptoms in Myasthenia Gravis
JNNP 84:989-994, Suzuki, S.,et al, 2013
A 35-Year-Old Woman with Acute Seizures and Behavior Change
Neurol 81:e55-e59, Rejeski, J.J.,et al, 2013
MRI-Identified Pathology in Adults with New-Onset Seizures
Neurol 81:920-927, Hakami, T.,et al, 2013
Brain Injury Patterns in Hypoglycemia in Neonatal Encephalopathy
AJNR 34:1458-1461, Wong, D.S.T.,et al, 2013
Characterising Aggressive Multiple Sclerosis
JNNP doi:10.1136 1-7, Menon, S.,et al, 2013
Paediatric Autoimmune Encephalopathies: Clinical Features, Laboratory Investigations and Outcomes in Patients with or without Antibodies to known Central Nervous System Autoantigens
JNNP 84:748-755, Hacohen, Y.,et al, 2013
Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013
Plasmablastic Lymphoma after Standard-Dose Temozolomide for Newly Diagnosed Glioblastoma
Neurol 81:93-94, Clark, S.,et al, 2013
The Spectrum of Statin Myopathy
Curr Opin Rheumatol 25:747-752, Mohassel, P. & Mammen, A.L., 2013
Mycoplasma Pneumoniae Infection: Neurologic Complications
www.MedLink.com, Oct, Greenlee, J.E., 2013
Hemiballism in a Patient with Parietal Lobe Infarction
Neurol 80:e22, Wu, M.C.,et al, 2013
A Trial of Scheduled Deep Brain Stimulation for Tourette Syndrome
JAMA Neurol 70:85-94, Okun, M.,et al, 2013
Neurostimulation for Parkinsons Disease with Early Motor Complications
NEJM 368:610-622, Rau, W.,et al, 2013
Pearls and Oysters: Carotid Dissection with Normal Arterial Lumen
Neurol 80:e115-e117, Pongmoragot, J.,et al, 2013
Autoimmune Chorea in Adults
Neurol 80:1133-1144, OToole, O.,et al, 2013
Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013
Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013
Retrospective Review of Cerebral Mycotic Aneurysms in 26 Patients: Focus on Treatment in Strongly Immunocompromised Patients with a Brief Literature Review
AJNR 34:823-827, Allen, L.M.,et al, 2013
Computed Tomography Angiography in Hyperacute Ischemic Stroke
Stroke 44:1480-1488, Mortimer, A.,et al, 2013
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Refractory Anorexia Nervosa: A Phase 1 Pilot Trial
Lancet 381:1361-1370,1338, Lipsman, N.,et al, 2013
Human Herpes 6 Virus Encephalitis Complicating Allogeneic Hematopoietic Stem Cell Transplantation
Neurol 80:1494-1500, Bhanushali, M.,et al, 2013
Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012
Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012
Central Nervous System Aspergillosis
Medicine 91:328-336, Kourkoumpetis, T.,et al, 2012
Emerging Subspecialties in Neurology: Neuroimmunology
Neurol 79:e178-e180, Clardy, S., 2012
Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised
Neurol 79:2125-2132, Tan, L.,et al, 2012
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy
Neurol 79:2349-2354, Morita, M.,et al, 2012
Diagnostic approach to Restricted-Diffusion Patterns on MR Imaging
Neurol Clin Pract 2:287-293, Finelli, P.F., 2012
Adult-Onset Opsoclonus-Myoclonus Syndrome
Arch Neurol 69:1598-1607, Klaas, J.,et al, 2012
An Unexpected Trismus
Lancet 380:536, Alves, M.,et al, 2012
Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012
Clinicopathologic Conference, Paraneoplastic Stiff Person Syndrome with Limbic Encephalitis with Anti-Amphiphysin Antibodies with Metastatic Carcinoma of Breast
NEJM 367:851-861, Case 27-2012, 2012
Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012
Deep-Brain Stimulation for Parkinsons Disease
NEJM 367:1529-1538, Okon, M.S., 2012
Neurologic Manifestations of E Coli infection - induced Hemolytic-Uremic Syndrome in Adults
Neurol 79:1466-1473, Weissenborn, K.,et al, 2012
Neurologic Complications of Influenza A (H1N1)pdm09
Neurol 79:1474-1481, Khandaker,G.,et al, 2012
Multimodal Monitoring in Subarachnoid Hemorrhage
Stroke 43:1440-1445, Sandsmark, D.K.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Extreme Delta Brush
Neurol 79:1094-1100, Schmitt, S.E.,et al, 2012
Generalised Periodic Discharges in the Critically Ill
Neurol 79:1951-1960,1940, Foreman, B.,et al, 2012
Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012